1. A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS. Issue 1 (10th January 2022) Authors: Katz, Jonathan S.; Rothstein, Jeffrey D.; Cudkowicz, Merit E.; Genge, Angela; Oskarsson, Björn; Hains, Avis B.; Chen, Chen; Galanter, Joshua; Burgess, Braydon L.; Cho, William; Kerchner, Geoffrey A.; Yeh, Felix L.; Ghosh, Arundhati Sengupta; Cheeti, Sravanthi; Brooks, Logan; Honigberg, Lee; Couch... Journal: Annals of clinical and translational neurology Issue: Volume 9:Issue 1(2022) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗